anmelden
SPI
18.574,54
PKT
-62,04
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.01.16 | Richemont overweight | JP Morgan Chase & Co. | |
| 15.01.16 | Holcim Neutral | BNP PARIBAS | |
| 14.01.16 | Richemont buy | S&P Capital IQ | |
| 14.01.16 | UBS Outperform | RBC Capital Markets | |
| 14.01.16 | UBS Sell | Société Générale Group S.A. (SG) | |
| 14.01.16 | UBS Market Perform | Cowen and Company, LLC | |
| 14.01.16 | Roche buy | Jefferies & Company Inc. | |
| 14.01.16 | Novartis buy | Jefferies & Company Inc. | |
| 14.01.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 14.01.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 14.01.16 | UBS Neutral | Credit Suisse Group | |
| 13.01.16 | UBS overweight | Morgan Stanley | |
| 13.01.16 | UBS overweight | Morgan Stanley | |
| 13.01.16 | Novartis Halten | Independent Research GmbH | |
| 13.01.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 13.01.16 | Givaudan overweight | JP Morgan Chase & Co. | |
| 13.01.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 13.01.16 | Richemont buy | Goldman Sachs Group Inc. | |
| 13.01.16 | Richemont overweight | Barclays Capital | |
| 13.01.16 | Givaudan buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 12.01.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 12.01.16 | UBS overweight | JP Morgan Chase & Co. | |
| 12.01.16 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 12.01.16 | Richemont buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.16 | Nestlé buy | Nomura | |
| 11.01.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 11.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 11.01.16 | Richemont overweight | JP Morgan Chase & Co. | |
| 11.01.16 | Roche buy | UBS AG | |
| 11.01.16 | UBS Neutral | UBS AG | |
| 11.01.16 | Novartis kaufen | UBS AG | |
| 11.01.16 | Nestlé Underperform | BNP PARIBAS | |
| 11.01.16 | Givaudan Outperform | BNP PARIBAS | |
| 11.01.16 | Zurich Insurance overweight | Barclays Capital | |
| 11.01.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.16 | Novartis Hold | Deutsche Bank AG | |
| 08.01.16 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. |